However, CXCL9 levels were significantly higher in the CD3 + T cell dominant tumors compared to NK cell dominant tumors in all (p = 0.0044) as well as the ccRCC cases (p = 0.03) (Fig. 3Cii and Supplementary Fig. S5Cii, respectively). The gene discussed is CXCL9; the disease is nonpapillary renal cell carcinoma.